Federal authorities are breathing a temporary sigh of relief as a last-ditch effort to delay a ban on most hemp-derived THC products has been narrowly rejected. The Senate voted 61-32 to table a bipartisan amendment from Senator Ted Budd (R-N.C.) and a dozen other lawmakers, which would have stripped a one-month delay from a stopgap government funding bill. The delay, set to take effect in mid-September, would have given the FDA and other regulatory agencies more time to finalize rules governing the sale of hemp-derived THC products. However, the Senate's decision means that the ban is now on track to take effect as scheduled, sparking concerns among industry stakeholders and advocates who argue that the products pose minimal health risks and should be allowed to remain on the market.
A federal ban on most hemp-derived THC products is set to be delayed for a month after a last-minute effort to keep the original timeline failed. The Senate voted 61-32 to table a bipartisan amendment from Sen. Ted Budd (R-N.C.) and about a dozen other senators to strip the delay from a stopgap government funding...
